Table of Contents
ISRN Urology
Volume 2011 (2011), Article ID 392014, 5 pages
http://dx.doi.org/10.5402/2011/392014
Research Article

Assessment of the Effects of Zoledronic Acid Therapy on Bone Metabolic Indicators in Hormone-Resistant Prostate Cancer Patients with Bone Metastatasis

1Department of Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey
2Department of Nuclear Medicine, Erciyes University Faculty of Medicine, Kayseri, Turkey

Received 17 February 2011; Accepted 4 April 2011

Academic Editors: P.-L. Chang and F. Staerman

Copyright © 2011 Abdullah Demirtas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Abdullah Demirtas, Nurettin Sahin, Mehmet Caniklioglu, Mustafa Kula, Oguz Ekmekcioglu, and Atila Tatlisen, “Assessment of the Effects of Zoledronic Acid Therapy on Bone Metabolic Indicators in Hormone-Resistant Prostate Cancer Patients with Bone Metastatasis,” ISRN Urology, vol. 2011, Article ID 392014, 5 pages, 2011. doi:10.5402/2011/392014